DENVER, Feb. 14, 2018 -- 361 Capital, a leading boutique asset manager offering distinctive investment strategies to institutions, investment advisors and their clients, has named two new sales directors to support its growing business.
Jeffrey Hood has been named sales director, Midwest region, for the firm. Hood joins 361 Capital from Janus Henderson Investors, where he was responsible for distribution of mutual funds, separate accounts and ETFs to registered investment advisors (RIAs) and independent/regional broker-dealers in New York and Connecticut. Before that he held roles at Wells Fargo Advisors and JP Morgan Chase. Hood received a bachelor’s degree in economics and environmental policy from the College of William and Mary. He holds FINRA Series 7 and 63 licenses.
Toller Miller, CIMA®, has been named sales director, Southeast region. Miller joins the firm from Oppenheimer Funds in Denver, where he served as vice president and senior advisor consultant for its Southeast region. He previously held roles at Commonwealth Financial Group and Janus Henderson Investors. Miller received a bachelor’s degree in Mass Communications from Kansas State University. He holds FINRA Series 7 and 63 licenses.
Hood and Miller are based in Denver and report to Josh Vail, CAIA, senior vice president and director of sales, who has been with the firm for nearly eight years. 361 Capital now has 10 people on its sales team, including six sales directors covering the Northeast, Great Lakes, Midwest, Mountain/South, Southeast, and West Coast regions.
“Jeff and Toller bring significant experience in sales and distribution to the firm, and we’re delighted to have them on the team,” said Josh Vail. “Our business is growing, and they will be responsible for helping us continue to reach investors who are looking for distinctive alternative and traditional investment strategies while managing risk in this environment.”
About 361 Capital
361 Capital is a leading boutique asset manager focused on delivering distinctive investment solutions to institutions, advisors and their clients. Founded in 2001, the firm offers alternative and traditional long-only equity strategies at the cutting edge of evolving markets—uniquely designed to meet investor goals of growth, risk management and diversification.
361 Capital is majority employee-owned with strategic investments from Lovell Minnick Partners, a private equity firm and Lighthouse Investment Partners.
For more information, call 866-361-1720 or visit 361capital.com.
Note: The CIMA professional qualification is administered by the Chartered Institute of Management Accountants. The CAIA charter is administered by the Chartered Alternative Investment Association.
| Media Relations Contacts | ||||
| Margaret Kirch Cohen | Sarah Lazarus | |||
| CL-Media Relations, LLC | CL-Media Relations, LLC | |||
| +1 847 507 2229 | +1 617 335 7823 | |||
| [email protected] | [email protected] | |||


Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
How Marco Pharma International Preserves German Homeopathic Traditions in America
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 



